Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00417703 · ClinicalTrials.gov registry record
Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
A clinical trial, sponsored by Oklahoma State University Center for Health Sciences.
- Completed
- Registry status
- 75
- Enrollment target
NCT00417703 is a clinical trial that has completed, run by Oklahoma State University Center for Health Sciences. The registered enrollment target is 75 participants.
The verdict
NCT00417703 has completed, sponsored by Oklahoma State University Center for Health Sciences.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study will quantify the intraocular pressure elevation in the immediate time period following intravitreous injection. With more widespread use of intravitreous injections in patients that may require several injections per year, it is important to document the sudden increase in intraocular pressure, including the maximum intraocular pressure and the time required for the intraocular pressure to return to baseline. This data may be useful in stimulating additional studies to evaluate the long term ocular effects of repeated intravitreous injections. We hypothesize that the intraocular pressure increases significantly following intravitreous injection and then returns to baseline during the initial thirty minutes following ranibizumab injection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00417703
The ClinicalTrials.gov registry entry for NCT00417703 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oklahoma State University Center for Health Sciences, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00417703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00417703 about?
NCT00417703 is a clinical study titled "Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab". This study will quantify the intraocular pressure elevation in the immediate time period following intravitreous injection. With more widespread use of intravitreous injections in patients that may require several injections per year, it is important to document the sudden increase in intraocular pr...
What is the current status of trial NCT00417703?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2007-01. Estimated completion is 2008-01.
Who is sponsoring clinical trial NCT00417703?
This trial is sponsored by Oklahoma State University Center for Health Sciences, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.